STAT3 and prostate cancer: In a study by Liu et al., it was found that sustained activation of STAT3 in prostate cancer cells led to the emergence of androgen-resistant prostate cancer, while downregulation of STAT3 activation levels resulted in prostate cancer cells being sensitive to chemotherapeutic agents again 15.